TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer September 17, 1977